Cargando…
Genome-wide cell-free DNA screening: a focus on copy-number variants
PURPOSE: Of 86,902 prenatal genome-wide cell-free DNA (cfDNA) screening tests, 4,121 were positive for a chromosome abnormality. This study examines 490 cases screen-positive for one or more subchromosomal copy-number variants (CNV) from genome-wide cfDNA screening. METHODS: Cases positive for one o...
Autores principales: | Rafalko, Jill, Soster, Erica, Caldwell, Samantha, Almasri, Eyad, Westover, Thomas, Weinblatt, Vivian, Cacheris, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486654/ https://www.ncbi.nlm.nih.gov/pubmed/34155363 http://dx.doi.org/10.1038/s41436-021-01227-5 |
Ejemplares similares
-
Application of mosaicism ratio to multifetal gestations
por: Rafalko, Jill, et al.
Publicado: (2021) -
Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations
por: Soster, Erica, et al.
Publicado: (2023) -
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
por: Soster, Erica, et al.
Publicado: (2021) -
Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
por: Soster, Erica, et al.
Publicado: (2023) -
Impact of mosaicism ratio on positive predictive value of cfDNA screening
por: Rafalko, Jill M., et al.
Publicado: (2020)